Connection

Gerardo Botti to Pneumonia, Viral

Back to Details
This is a "connection" page, showing publications Gerardo Botti has written about Pneumonia, Viral.
Gerardo Botti
Connection Strength
0.079
Pneumonia, Viral
  1. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer. Front Immunol. 2020; 11:588724.
    View in: PubMed
    Score: 0.029
  2. PI3Kd Inhibition as a Potential Therapeutic Target in COVID-19. Front Immunol. 2020; 11:2094.
    View in: PubMed
    Score: 0.029
  3. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2020 10 21; 18(1):405.
    View in: PubMed
    Score: 0.007
  4. TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol. Contemp Clin Trials. 2020 11; 98:106165.
    View in: PubMed
    Score: 0.007
  5. A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave? J Exp Clin Cancer Res. 2020 Jun 11; 39(1):109.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.